Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,449,194
+$233,426 QoQ
Shares Held
5,759
+3.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#894
of 1,872 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VALLEY NATIONAL ADVISERS INC holds $26,573,081 across 16 Drug Manufacturers - General names. ABBV ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,036 | $6,040,329 | |
| 2 | MRK |
Merck & Co., Inc.
|
44,957 | $5,776,974 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
30,848 | $3,897,336 | |
| 4 | AMGN |
Amgen Inc
|
10,266 | $3,717,523 | |
| 5 | AZN |
Astrazeneca PLC
|
13,217 | $2,506,207 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
5,759 | $1,449,194 | |
| 7 | NVS |
Novartis AG
|
7,794 | $1,221,475 | |
| 8 | JNJ |
Johnson & Johnson
|
3,962 | $1,006,229 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,449,194 | 5,759 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,215,768 | 5,590 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,289,369 | 5,643 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,301,254 | 5,620 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,040,956 | 5,608 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,154,664 | 5,511 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $907,158 | 5,105 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $986,215 | 4,994 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $972,689 | 5,671 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,021,034 | 5,607 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $856,364 | 5,526 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $995,124 | 6,676 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $937,990 | 6,962 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,138,061 | 7,141 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $1,152,925 | 7,134 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $1,001,609 | 7,463 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,134,762 | 7,409 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $2,043,882 | 12,608 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,657,566 | 12,242 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,321,623 | 12,252 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,382,205 | 12,271 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,316,063 | 12,161 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,296,300 | 12,098 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,120,013 | 12,787 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,246,296 | 12,694 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $969,136 | 12,720 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||